Dienstag, 16. Januar 2018

  • Pressemitteilung BoxID 336623

4SC to host conference call on 9 August 2012 to present Q2 2012 results

Planegg-Martinsried, (lifePR) - 4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, will announce results of the 4SC Group for the second quarter of 2012 and publish the Company's half year report 2012 on 9 August 2012. On this day the Management Board of 4SC will host a conference call at 3pm CEST (9am EDT) to inform about the consolidated financial statements in the reporting period and provide further details on the Company's latest developments.

Participants can access the conference call under the following telephone numbers:

Date: 9 August 2012
Time: 3pm CEST (9am EDT)
Dial-in numbers:
+49-6103-485-3000 (Germany)
+44-207-153-2027 (UK)
+1-480-629-9870 (USA)
+49-6103-485-3000 (other countries)
Conference-ID: 4557873

Approximately two hours after the start of the live presentation, an audio replay will be available at 4SC's website www.4sc.com in the section "Investors / Events & Presentations / Conference calls & Webcasts".

Legal Note

This document may contain projections or estimates relating to plans and objectives relating to our future operations, products, or services; future financial results; or assumptions underlying or relating to any such statements; each of which constitutes a forward-looking statement subject to risks and uncertainties, many of which are beyond our control. Actual results could differ materially, depending on a number of factors.


The Group managed by 4SC AG (ISIN DE0005753818) discovers and develops targeted, small-molecule drugs for treating diseases with high unmet medical needs in various autoimmune and cancer indications. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, and provide a better quality of life. The Company's balanced pipeline comprises promising products that are in various stages of clinical development. 4SC's aim is to generate future growth and enhance its enterprise value by entering into partnerships with leading pharmaceutical companies. Founded in 1997, 4SC had 90 employees at 31 March 2012. 4SC AG has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005.

Diese Pressemitteilungen könnten Sie auch interessieren

marbet erstmals unter Top 5 im Kreativranking

, Medien & Kommunikation, marbet Marion & Bettina Würth GmbH & Co. KG

Komplettiert wurde das erfolgreiche Awardjahr der marbet mit bislang 14 Auszeichnungen durch den goldenen BEA Award für die HottrendsXhibition...

England: Internationales adventistisches Malbuch für Erwachsene

, Medien & Kommunikation, Freikirche der Siebenten-Tags-Adventisten in Deutschland / Süddeutscher Verband KdöR

Anfang Januar veröffentlichte die Abteilung Frauen der teilkontinentalen Kirchenleitung der Siebenten-Tags-Adventisten in Nord- und Südosteuropa...

Verbände Druck und Medien starten Branchenbefragung zur wirtschaftlichen Lage

, Medien & Kommunikation, Bundesverband Druck und Medien e.V.

Das Wissen über die aktuelle Verfassung der Branche sowie über die Trends des Geschäftsumfelds spielt für jedes Druck- und Medienunternehmen...